HomeAYTU • NASDAQ
add
Aytu Biopharma Inc
Previous close
$1.92
Day range
$1.91 - $2.03
Year range
$1.90 - $3.45
Market cap
11.91M USD
Avg Volume
27.74K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Insider Monkey
5 hours ago
Is Concentrix Corporation (CNXC) an Oversold NASDAQ Stock to Invest In Now?
2.35%
0.54%
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 17.98M | -41.51% |
Operating expense | 13.44M | -14.73% |
Net income | -4.62M | -87.91% |
Net profit margin | -25.68 | -221.40% |
Earnings per share | — | — |
EBITDA | 1.14M | -76.75% |
Effective tax rate | -17.72% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.01M | -12.96% |
Total assets | 118.10M | -13.46% |
Total liabilities | 90.38M | -6.93% |
Total equity | 27.72M | — |
Shares outstanding | 6.15M | — |
Price to book | 0.41 | — |
Return on assets | -1.62% | — |
Return on capital | -4.27% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -4.62M | -87.91% |
Cash from operations | -788.00K | -108.41% |
Cash from investing | -34.00K | 78.06% |
Cash from financing | 1.07M | 119.76% |
Net change in cash | 246.00K | -93.54% |
Free cash flow | 313.50K | -96.00% |
About
Founded
2002
Headquarters
Website
Employees
99
